Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Peter U. Ardelt"'
Autor:
Peter U Ardelt, Jan Ebbing, Fabian Adams, Cora Reiss, Wadih Arap, Renata Pasqualini, Alexander Bachmann, Ulrich Wetterauer, Hubertus Riedmiller, Burkhard Kneitz
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0118646 (2015)
BackgroundTo use combinatorial epitope mapping ("fingerprinting") of the antibody response to identify targets of the humoral immune response in patients with transitional cell carcinoma (TCC) of the bladder.MethodsA combinatorial random peptide libr
Externí odkaz:
https://doaj.org/article/5c6a17c655c14e4aa5244ec25d2536fb
Autor:
Per-Uno Malmström, Núria Malats, Vincenzo Serretta, Renzo Colombo, Richard Sylvester, Savino M. Di Stasi, Bas W.G. van Rhijn, Shahrokh F. Shariat, Paolo Gontero, Anne J. Grotenhuis, Marek Babjuk, Riccardo Bartoletti, Steven Joniau, Jack Baniel, T. Tony Cai, Jeffrey Karnes, Martin Spahn, Joan Palou, J. Varkarakis, Francesco Soria, J. Irani, Peter U. Ardelt, David D'Andrea, Guido Dalbagni, Eugene K. Cha, Stéphane Larré
Publikováno v:
World Journal of Urology
WORLD JOURNAL OF UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
WORLD JOURNAL OF UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Purpose To investigate the association of patients’ sex with recurrence and disease progression in patients treated with intravesical bacillus Calmette–Guérin (BCG) for T1G3/HG urinary bladder cancer (UBC). Materials and methods We analyzed the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54590286726fd917b319ad019f9dead4
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-470099
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-470099
Autor:
Christian Wetterauer, Frank Friedersdorff, Peter U. Ardelt, Justin W. Collins, Carsten Kempkensteffen, Jan Ebbing, Jonas Busch, Hans Helge Seifert, Paolo Frumento, Christofer Adding, Florian Fuller, Kurt Miller
Publikováno v:
Journal of Urology. 197
Autor:
Peter U. Ardelt, Felix Burkhalter
Publikováno v:
Urology. 88
Publikováno v:
BJU International. 109:288-297
Study Type – Prognosis (case series) Level of Evidence 4 What’s known on the subject? and What does the study add? While the ileal conduit and orthotopic neobladder are the most commonly used diversions today, continent cutaneous reservoirs remai
Autor:
Renata Pasqualini, Catherine A. Moya, Limor Chen, Kenneth C. Wright, Wadih Arap, Christopher G. Wood, Paul J. Mintz, Peter U. Ardelt, Marco A. Arap
Publikováno v:
Journal of Urology. 169:1535-1540
With the goal of targeting the human bladder using phage display technology we designed and tested a tissue binding assay on intact urothelium ex vivo. This approach may form the molecular basis for clinical development of peptide or peptidomimetic g
Autor:
T. Tony Cai, Anne J. Grotenhuis, Francesca Pisano, J. Varkarakis, Viktor Soukup, Jeffrey Karnes, Vincenzo Serretta, Renzo Colombo, Savino M. Di Stasi, Alberto Briganti, Núria Malats, Stéphane Larré, bas van Rhjin, Eugene K. Cha, Alfred Witjes, Juan Palou, J. Irani, Jack Baniel, Per-Uno Malmström, Richard Sylvester, Peter U. Ardelt, Guido Dalbagni, Roy Mano, Riccardo Bartoletti, Steven Joniau, Paolo Gontero, Kathy Vander Eeckt, Martin Spahn, Marek Babjuk, Sharok Shariat
Publikováno v:
Journal of Urology. 189
Prognostic Factors And Risk Groups In T1g3 Patients Initially Treated With Bcg : Results Of A Multicenter Retrospective Series In 1743 Patients
Publikováno v:
BJU international. 109(2)
To critically assess the biophysical properties and current status of outlet formation in heterotopic intestinal urinary diversion. As despite three decades of clinical experience with continent cutaneous urinary diversion through bowel segments, no
Autor:
Burkhard Kneitz, Renata Pasqualini, P. Adam, Limor Chen, Arkadius Kocot, Joachim Fensterle, Hubertus Riedmiller, Cora Reiss, Peter U. Ardelt, Elmar W. Gerharz, Wadih Arap
Publikováno v:
Cancer. 116(3)
BACKGROUND: Intravesical immunotherapy with Mycobacterium bovis (M. bovis) bacillus Calmette-Guerin (BCG) is the current standard of care against superficial, high-grade transitional cell carcinoma (TCC) of the urinary bladder (carcinoma in situ and
Publikováno v:
Cancer. 117:872-873